MSNBC seems upset


The FDA announced Friday that it is postponing the meeting because “new data have recently emerged.  This will give the agency time to consider the additional data, allowing for a transparent public discussion as part of our usual scientific and regulatory processes for COVID-19 vaccines. We will provide an update on timing for the advisory committee meeting once we receive additional data on a third dose in this age group from the company’s ongoing clinical trial and have an opportunity to complete an updated evaluation.”



No comments:

Post a Comment